Thus, SFPQ significantly attenuates TGF-β‘s tumor-suppressive activities, thereby altering the cellular response to TGF-β and potentially promoting conditions that favor tumorigenesis and cancer progression (Fig. 6a). This evidence concerns the gene TGFB1 and neoplasm.